Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

ACST

Acasti Pharma (ACST)

Acasti Pharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ACST
DateHeureSourceTitreSymboleSociété
10/05/202422h11Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ACSTAcasti Pharma Inc
09/05/202401h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
12/02/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACSTAcasti Pharma Inc
12/02/202413h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACSTAcasti Pharma Inc
08/01/202414h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACSTAcasti Pharma Inc
17/10/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACSTAcasti Pharma Inc
16/10/202322h31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACSTAcasti Pharma Inc
10/10/202313h40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ACSTAcasti Pharma Inc
06/10/202322h30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ACSTAcasti Pharma Inc
25/08/202323h01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ACSTAcasti Pharma Inc
25/08/202322h21Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ACSTAcasti Pharma Inc
25/08/202322h15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ACSTAcasti Pharma Inc
10/07/202315h00PR Newswire (US)Acasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON Pivotal Phase 3 Safety Trial for GTX-104 in aSAH PatientsNASDAQ:ACSTAcasti Pharma Inc
07/07/202314h00PR Newswire (US)Acasti Pharma Announces 1-for-6 Reverse Stock SplitNASDAQ:ACSTAcasti Pharma Inc
05/07/202315h00PR Newswire (US)Acasti Announces Alignment with FDA on GTX-104 Pivotal Phase 3 Safety Trial Protocol and Confirms Planned Initiation of STRIVE-ON in aSAH Patients in Calendar Q4 2023NASDAQ:ACSTAcasti Pharma Inc
23/06/202313h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ACSTAcasti Pharma Inc
23/06/202313h00PR Newswire (US)Acasti Pharma Reports Fiscal Year 2023 Operational ResultsNASDAQ:ACSTAcasti Pharma Inc
22/06/202315h00PR Newswire (US)Acasti Announces Appointment of New Scientific Advisory Board MembersNASDAQ:ACSTAcasti Pharma Inc
26/05/202321h07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ACSTAcasti Pharma Inc
17/05/202315h00PR Newswire (US)Acasti to Participate in the Lytham Partners Spring 2023 Investor ConferenceNASDAQ:ACSTAcasti Pharma Inc
08/05/202313h00PR Newswire (US)Acasti Successfully Submits Pivotal GTX-104 Phase 3 Safety Study Protocol with FDA and Implements Strategic Realignment Plan That Extends Projected Cash Runway Through Calendar Q2 2025NASDAQ:ACSTAcasti Pharma Inc
05/04/202323h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACSTAcasti Pharma Inc
04/04/202314h01PR Newswire (US)Acasti to Proceed with Phase 3 Clinical Safety Study for GTX-104 Following FDA Feedback, and Upon Approval of the Full Study Protocol to be Submitted to the INDNASDAQ:ACSTAcasti Pharma Inc
04/04/202314h00PR Newswire (US)Acasti Announces Appointment of Prashant Kohli as CEONASDAQ:ACSTAcasti Pharma Inc
30/03/202314h30PR Newswire (US)Acasti Pharma Inc. Announces the Resignation of a DirectorNASDAQ:ACSTAcasti Pharma Inc
13/03/202313h00PR Newswire (US)Acasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture ExchangeNASDAQ:ACSTAcasti Pharma Inc
08/03/202315h00PR Newswire (US)Acasti Pharma to Participate in Oppenheimer 33rd Annual Healthcare ConferenceNASDAQ:ACSTAcasti Pharma Inc
28/02/202319h00PR Newswire (US)Acasti Pharma Recognizes Rare Disease DayNASDAQ:ACSTAcasti Pharma Inc
14/02/202313h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACSTAcasti Pharma Inc
14/02/202313h00GlobeNewswire Inc.Acasti Pharma Reports Third Quarter 2023 Operational ResultsNASDAQ:ACSTAcasti Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:ACST

Dernières Valeurs Consultées

Delayed Upgrade Clock